Decreased levels of serum glutathione peroxidase 3 are associated with papillary serous ovarian cancer and disease progression

Table 2 Summary of data from Figure 1A and 1B

Variable	Control	All Patients	Early	Late	Recurrent
Number of samples (n)	65	66	22	31	13
GPX3 concentration (ng/ml)
*Median*	27.8	22.4	28.1	18.5	14.7
*Maximum*	53.7	49.5	49.5	44.6	48.9
*Minimum*	8.7	4.5	14.4	4.5	7.7
Statistical Analysis: Mann Whitney U test (p-value)
*Vs. Controls*		1 × 10 ^-2	0.6	9 × 10 ^-4	1 × 10 ^-2
*Vs. Early stage samples*				5 × 10 ^-4	1 × 10 ^-2

Comparison of all samples indicates that GPX3 levels significantly decrease in patients and are correlated with stage. p-values indicating statistically significant differences are shown in bold.

ISSN: 1757-2215